…
SureNano Science Ltd. engages in the distribution and sale of surfactant in Canada and the United States. It offers SureNano surfactant, a ready-to-mix food-grade compound that provides the base for high performance nano-emulsions to create homogeneous and stable products. SureNano Science Ltd. was incorporated in 2021 and is headquartered in Vancouver, Canada.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Publicly available information on SureNano Science Ltd is limited, with company filings and investor disclosures not readily accessible. Because of that, long-term growth drivers are unclear and investors seeking exposure to early-stage nanotechnology or advanced materials should treat the company as having significant informational uncertainty.
Material investment risks include limited disclosure and transparency, absence of a verifiable operating track record, low trading liquidity, financing and execution risk, and technical and commercialization uncertainty.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
| Income before tax | -0.06M | -0.28M | -0.38M | -1.12M |
| Net income | -0.06M | -0.28M | -0.38M | -1.12M |
| Selling general administrative | 0.12M | 0.13M | 0.19M | 0.64M |
| Gross profit | - | - | 0.00M | 0.02M |
| Reconciled depreciation | 0.00M | 0.00M | 0.00M | 0.00M |
| Operating income | -0.24M | -0.28M | -0.39M | -1.12M |
| Tax provision | 0.00M | 0.00M | 0.00M | 0.00M |
| Total revenue | 0.00M | 0.00M | 0.00M | 0.02M |
| Total operating expenses | 0.24M | 0.28M | 0.39M | 1.14M |
| Cost of revenue | - | - | 0.00M | 0.00M |
| Total other income expense net | 0.18M | - | 0.01M | - |
| Net income from continuing ops | -0.06M | -0.28M | -0.38M | -1.12M |
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Total assets | 0.05M | 0.15M | 0.32M | 0.69M | 0.97M |
| Total liab | 0.13M | 0.17M | 0.06M | 0.04M | 0.02M |
| Total stockholder equity | -0.08M | -0.02M | 0.26M | 0.65M | 0.95M |
| Capital stock | 1.44M | 1.44M | 1.44M | 1.44M | 1.03M |
| Retained earnings | -1.92M | -1.87M | -1.59M | -1.20M | -0.08M |
| Cash | 0.02M | 0.13M | 0.28M | 0.67M | 0.93M |
| Total current liabilities | 0.13M | 0.17M | 0.06M | 0.04M | 0.02M |
| Total current assets | 0.05M | 0.15M | 0.31M | 0.69M | 0.97M |
| Net receivables | 0.00M | 0.00M | 0.02M | 0.02M | 0.04M |
| Accounts payable | 0.01M | 0.02M | 0.01M | 0.02M | 0.02M |
| Non current assets total | 0.00M | 0.01M | 0.01M | 0.00M | 0.00M |
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
| Investments | - | 0.00M | -0.01M | 0.00M |
| Total cash from financing activities | 0.05M | 0.00M | 0.00M | 0.41M |
| Net income | -0.06M | -0.28M | -0.38M | -1.12M |
| Change in cash | -0.11M | -0.14M | -0.39M | -0.26M |
| Begin period cash flow | 0.13M | 0.28M | 0.67M | 0.93M |
| End period cash flow | 0.02M | 0.13M | 0.28M | 0.67M |
| Total cash from operating activities | -0.16M | -0.14M | -0.38M | -0.67M |
| Issuance of capital stock | - | - | 0.00M | 0.44M |
| Depreciation | 0.00M | 0.00M | 0.00M | 0.00M |
| Change to account receivables | - | - | - | 0.02M |
| Capital expenditures | 0.00M | 0.00M | 0.02M | 0.00M |
| Change in working capital | 0.08M | 0.14M | 0.01M | 0.04M |
| Stock based compensation | - | 0.00M | -0.01M | 0.41M |
| Other non cash items | -0.18M | - | - | 0.00M |
| Free cash flow | -0.16M | -0.14M | -0.40M | -0.67M |
Sector: Basic Materials Industry: Specialty Chemicals
|
Stock Name
|
Change
(CAD) |
Price
(CAD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| SURE SureNano Science Ltd |
-0.01 4.00% |
0.12 | - | - | 206.79 | 5.82 | 160.04 | -2.25 |
| HG Hydrograph Clean Power Inc |
-0.33 8.05% |
3.77 | - | - | 37983.40 | 69.78 | 27413.68 | -4.96 |
| FNDX FendX Technologies Inc. |
0.01 2.50% |
0.20 | - | - | - | 22.12 | - | -5.98 |
SureNano Science Ltd. engages in the distribution and sale of surfactant in Canada and the United States. It offers SureNano surfactant, a ready-to-mix food-grade compound that provides the base for high performance nano-emulsions to create homogeneous and stable products. SureNano Science Ltd. was incorporated in 2021 and is headquartered in Vancouver, Canada.
| Name | Title | Year Born |
|---|---|---|
| Mr. Charles MaLette | CEO, President, Corporate Secretary & Director | 1945 |
| Mr. James Bordian | CFO & Director | 1941 |
| Dr. Nihar R. Pandey | Chief Scientific Officer & Director | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.